Showing results (111-120 of 261) with videos related to

Sort By:
Pageof 27
Respiratory Investigation|September 11, 2022
Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series studyYoshitaka Seki, Tatsuya Yoshida, Takashi Kohno, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2025
Evolving treatments and prognosis in Stage IV non-small cell lung cancer: 20 years of progress of novel therapiesHironori Satoh, Yusuke Okuma, Yuki Shinno, et al.
JTO Clinical and Research Reports|February 16, 2024
Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR MutationsYuki Takeyasu, Tatsuya Yoshida, Ken Masuda, et al.
Molecular Pharmacology|September 19, 2002
Conformation of ligands bound to the muscarinic acetylcholine receptorHiroyasu Furukawa, Toshiyuki Hamada, Mariko K Hayashi, et al.
Cancer Science|January 19, 2021
IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patientsMakoto Nishio, Haruhiro Saito, Koichi Goto, et al.
Anticancer Research|January 30, 2026
Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance StatusYoh Yamaguchi, Tatsuya Yoshida, Ryoko Inaba Higashiyama, et al.
Frontiers in Oncology|February 11, 2022
CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic TargetsJumpei Kashima, Tsunekazu Hishima, Yusuke Okuma, et al.
Respiratory Medicine Case Reports|February 2, 2022
An autopsy case of idiopathic pulmonary fibrosis with remarkable honeycomb cyst expansionYu Ito, Nobuyasu Awano, Minoru Inomata, et al.
Future Oncology (London, England)|January 17, 2022
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901)Yusuke Okuma, Mototsugu Shimokawa, Kana Hashimoto, et al.
Clinical Lung Cancer|May 26, 2022
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic TumorYuki Shinno, Akihiko Yoshida, Ken Masuda, et al.
Pageof 27